WallStreetZenWallStreetZen

NASDAQ: LIFE
Atyr Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LIFE

Based on 2 analysts offering 12 month price targets for Atyr Pharma Inc.
Min Forecast
$16.00+887.65%
Avg Forecast
$25.50+1,474.07%
Max Forecast
$35.00+2,060.49%

Should I buy or sell LIFE stock?

Based on 2 analysts offering ratings for Atyr Pharma Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LIFE stock forecasts and price targets.

LIFE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15
lockedlocked$00.00+00.00%2024-03-15

1 of 1

Forecast return on equity

Is LIFE forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is LIFE forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

LIFE revenue forecast

What is LIFE's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$500.0k+41.64%
Avg 2 year Forecast
$12.6M+3,469.41%
Avg 3 year Forecast
$95.3M+26,909.92%
LIFE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LIFE revenue growth forecast

How is LIFE forecast to perform vs Biotechnology companies and vs the US market?
Company
531.56%
Industry
37.96%
Market
10.23%
LIFE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LIFE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LIFE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LIFE$1.62$25.50+1,474.07%Buy
ANVS$9.85$25.00+153.81%Buy
OTLK$8.29$51.63+522.79%Strong Buy
PDSB$2.90$17.33+497.69%Strong Buy
SEER$1.75N/AN/A
View Top Biotech Stocks

Atyr Pharma Stock Forecast FAQ

Is Atyr Pharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: LIFE) stock is to Buy LIFE stock.

Out of 2 analysts, 0 (0%) are recommending LIFE as a Strong Buy, 2 (100%) are recommending LIFE as a Buy, 0 (0%) are recommending LIFE as a Hold, 0 (0%) are recommending LIFE as a Sell, and 0 (0%) are recommending LIFE as a Strong Sell.

If you're new to stock investing, here's how to buy Atyr Pharma stock.

What is LIFE's revenue growth forecast for 2024-2026?

(NASDAQ: LIFE) Atyr Pharma's forecast annual revenue growth rate of 531.56% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Atyr Pharma's revenue in 2024 is $353,000.On average, 1 Wall Street analysts forecast LIFE's revenue for 2024 to be $33,875,012, with the lowest LIFE revenue forecast at $33,875,012, and the highest LIFE revenue forecast at $33,875,012. On average, 1 Wall Street analysts forecast LIFE's revenue for 2025 to be $853,650,302, with the lowest LIFE revenue forecast at $853,650,302, and the highest LIFE revenue forecast at $853,650,302.

In 2026, LIFE is forecast to generate $6,459,626,038 in revenue, with the lowest revenue forecast at $1,828,573,148 and the highest revenue forecast at $11,090,678,929.

What is LIFE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LIFE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is LIFE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year LIFE price target, the average LIFE price target is $25.50, with the highest LIFE stock price forecast at $35.00 and the lowest LIFE stock price forecast at $16.00.

On average, Wall Street analysts predict that Atyr Pharma's share price could reach $25.50 by Mar 15, 2025. The average Atyr Pharma stock price prediction forecasts a potential upside of 1,474.07% from the current LIFE share price of $1.62.

What is LIFE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LIFE) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.